Moreover, serum BAFF level was associated with disease severity of ILD, and BAFF levels > 2971.5 pg/mL was an independent risk factor for RP-ILD in anti-MDA5+DM patient. This evidence concerns the gene TNFSF13B and dermatomyositis.